Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ZAGG Q4 Profit Surges, Tops Estimates

RELATED NEWS
Trade ZAGG now with 

ZAGG Inc. (ZAGG) Monday reported fourth-quarter net income of $9.9 million or $0.32 per share, rising from last year's $3.4 million or $0.13 per share. Earnings beat estimates.

In the quarter, ZAGG incurred an impairment charge of $0.4 million on its note receivable which was offset by a $1.9 million gain on the deconsolidation of HzO as ZAGG no longer has a controlling interest in HzO.

Excluding these items, non-GAAP net income for the quarter was $8.6 million or $0.27 per share, compared to $3.4 million or $0.14 per share last year.

On average, 4 analysts polled by Thomson Reuters expected the company to earn $0.20 per share for the quarter. Analysts' estimates typically exclude one-time items.

Net sales for the quarter increased to $67.5 million from $29.2 million last year. Analysts expected sales of $63.97 million for the quarter.

Robert G. Pedersen, CEO of the company, said, "ZAGG performed exceptionally well with record fourth quarter revenue and earnings, as the result of strong holiday sales, record online sales and an expanded SKU presence at our indirect channel to big-box retail partners for both ZAGG and iFrogz branded products. With the operating initiatives we have put in place, and our alignment around a product-centric structure, we are building a company that can keep pace with the global growth we are seeing for mobile device accessories in 2012 and beyond."

The company guided 2012 revenues in excess of $250 million. Analysts expect full-year 2012 revenues of $240.57 million.

Register
To receive FREE breaking news email alerts for Zagg Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.